Rep. Fitzpatrick, Bipartisan Group Urge Administration to Maintain Anti-Drug Funding
Congressmen
The Members wrote: "For almost two decades, ONDCP has had a critical role in ensuring the nation's drug policy is effective, accountable, and evidence-based. The Office and the programs it supports are uniquely positioned to address the causes and effects of the current opioid crisis with proven strategies and broad reach. For these important programs to remain effective, we believe they must continue to be funded fully and coordinated effectively. We are gravely concerned that any interruption would exacerbate the crises in our communities and we remain committed in working together to reverse the damaging effects that opioids and other drugs have had on American families."
With the deadly opioid epidemic tearing apart families and communities nationwide, the need for a coordinated, effective and accountable approach to substance abuse and drug trafficking is greater than ever.
Since its creation in 1988, ONDCP has enjoyed bipartisan support for its mission of protecting public safety and promoting public health. The office's National Drug Control Strategy has provided an important blueprint to guide and coordinate the efforts of federal, state, and local partners to ensure an evidence-based and accountable strategy to address the devastating impact of drugs on our communities.
The DFC program reduces drug use through building a multi-sector coalition where schools, parents, health care, and youth-serving organizations work together to plan and implement a comprehensive set of evidence-based programs tailored to a community's unique needs. More than 600 communities nationwide currently have
Click here and see below to read the letter: http://cummings.house.gov/sites/cummings.house.gov/files/documents/170516ONDCPLetter.pdf
Dear Director Mulvaney:
We are writing to express our concern about reported severe reductions to the
As you know, ONDCP has played a critical role in coordinating the nation's drug control efforts. Since 1988 this office has enjoyed bipartisan support for its mission of protecting public safety and promoting public health. The office's National Drug Control Strategy has provided an important blueprint to guide and coordinate the efforts of federal, state, and local partners to ensure an evidence-based and accountable strategy to address the devastating impact of drugs on our communities.
The need for a coordinated, effective, and accountable approach to substance abuse and drug trafficking is greater than ever.
The High Intensity Drug Trafficking Areas (HIDTA) program, overseen by ONDCP, has been a critical component of the National Drug Control Strategy. This program aids in the coordination of federal, state, and local drug task forces to disrupt or dismantle drug trafficking organizations. It also engages and provides support to state and federal prosecutors to convict individuals associated with drug trafficking organizations. In recent years, HIDTA seizures have yielded billions of dollars that transnational criminal organizations would have used to reinvest in the illegal drug trade. Instead, this cost-effective program has reinvested proceeds in efforts to further address the causes and effects of substance abuse.
The office's Drug Free Communities (DFC) Program has been similarly effective. Its approach to addressing local problems with community-driven solutions has consistently shown reductions in past 30-day use of alcohol, tobacco, and prescription drugs. The program is designed with strict accountability provisions to ensure the highest levels of local support in solving the substance abuse crisis each community faces. By law, there is a cap on the amount of money that can be spent on administrative and overhead expenses, which ensures that the maximum amount of funding goes to DFC coalitions that have the power to reduce youth substance use in their own communities. Coalitions are required to be in existence and fully functioning for a minimum of six months before they are eligible to apply, and they must have baseline data to show that they have full knowledge of local drug issues, as well as matching federal funding with dollar-for-dollar local funds.
For almost two decades, ONDCP has had a critical role in ensuring the nation's drug policy is effective, accountable, and evidence-based. The Office and the programs it supports are uniquely positioned to address the causes and effects of the current opioid crisis with proven strategies and broad reach. For these important programs to remain effective, we believe they must continue to be funded fully and coordinated effectively. We are gravely concerned that any interruption would exacerbate the crises in our communities and we remain committed in working together to reverse the damaging effects that opioids and other drugs have had on American families.
We respectfully request clarification on the Administration's intended actions to ensure the continuity of HIDTA and DFC and look forward to your response.
Sincerely,


AACN President Urges Advocacy, Engagement at UC College of Nursing
Members of Congress Invite Ivanka Trump to Meeting on Women’s Health Issues
Advisor News
- Inflation, competing priorities and uncertainty erode retirement security
- As health premiums rise, 1 in 8 workers cut retirement savings
- CT governor’s candidates claims: What’s true, and what’s misleading
- Retaining clients by giving them a memorable experience
- Addressing the longevity paradox
More Advisor NewsAnnuity News
- National Life Group expands annuity portfolio
- AM Best to Join Life/Annuity Insurance-Focused Panel Discussion at Capitol Forum Event
- USAA Earns No. 1 Ranking in JD Power Individual Annuity Study for the Third Consecutive Year
- How flexible annuities fit today’s retirement portfolios
- Foresters Financial appoints Tom Ross as chief distribution officer for U.S. annuity sales
More Annuity NewsHealth/Employee Benefits News
- How the law protecting Americans from surprise medical bills is driving up healthcare costs
- Your Georgia Auto Policy Speaks English — Here's How to Read the Fine Print
- Pennsylvania Law Mandates No-Cost Coverage for Colorectal Cancer Blood Tests
- Open Enrollment set to begin Nov. 1
- Advice for health care open enrollment beginning November 1
More Health/Employee Benefits NewsLife Insurance News